Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 Diabetes Mellitus Condition: Initial treatment |
Dose: Tablet – 2.5 mg/250 mg (glipizide/metformin) Frequency: once daily Note: Take by mouth with food. May adjust daily dose in increments of 1 tablet every 2 weeks. Maximum: Glipizide 10 mg and metformin 2,000 mg daily. Hepatic impairment: Contraindicated. |
|
Indication: Type 2 Diabetes Mellitus Condition: Initial treatment with fasting plasma glucose = 280-320 mg/dL |
Dose: Tablet – 2.5 mg/500 mg (glipizide/metformin) Frequency: every 12 hours Note: Take by mouth. May adjust daily dose in increments of 1 tablet every 2 weeks. Maximum: Glipizide 10 mg and metformin 2,000 mg daily. Hepatic impairment: Contraindicated. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Not applicable – No approved dosage Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Estimated glomerular filtration rate less than 30 mL/minute/1.73 m² |
Dose: Metformin – Not applicable Note: Contraindicated; If estimated glomerular filtration rate falls below 30 mL/minute/1.73 m² while taking metformin, discontinue the drug |
|
Condition: Estimated glomerular filtration rate 30-45 mL/minute/1.73 m² |
Dose: Metformin – Not recommended to initiate treatment Note: If estimated glomerular filtration rate falls below 45 mL/minute/1.73 m² while taking metformin, risks and benefits of continuing therapy should be evaluated |
Administration
- Take with meals
- Regular timing
Side Effect
- Glipizide GI upsets
- diarrhoea
- nausea
- allergic skin reactions
- leucopaenia
- thrombocytopaenia
- agranulocytosis
- hyponatraemia
- jaundice
- haemolytic anaemia
- pancytopaenia
- Metformin Anorexia
- nausea
- vomiting
- diarrhoea
- weight loss
- flatulence
- occasional metallic taste
- weakness
- hypoglycaemia
- rash
- malabsorption of Vitamin
- Glipizide Hypoglycaemia in presence of renal or hepatic damage and alcohol
- Metformin Lactic acidosis in presence of renal failure and alcoholism
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Beta-blockers (Propranolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol, Nadolol, Timolol, Sotalol), Cholestyramine, Hydantoins, Thiazide diuretics (Chlorothiazide, Chlorthalidone, Hydrochlorothiazide, Indapamide, Metolazone), Urinary alkalinizers
|
Decreased effect (Glipizide)
|
|
Fluconazole, Gemfibrozil, Ketoconazole, NSAIDs (Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam, Indomethacin, Piroxicam, Ketorolac), Pioglitazone, Sulfonamides
|
Increased glipizide levels and effects (Glipizide)
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Type 2 Diabetes Mellitus, Ketoacidosis
|
Can worsen metabolic complications
|
|
Severe Renal and Hepatic Insufficiency
|
Can cause drug accumulation
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 25ºC in a cool and dry place.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.